​  Danish    Norsk  Svensk   English   Suomi

At MEQnordic we are proud to introduce UroLift, a minimally invasive Benign Prostate Hypoplasia (BPH) treatment.

BPH is a condition in which the prostate enlarges as men get older. BPH is a very common condition and is unrelated to prostate cancer.

UroLift provides a lasting result, by lifting and holding the prostate tissue so it no longer blocks the urethra.

It is the only BPH treatment performed by a urologist that does not require heating, cutting or removal of the prostate tissue.​

UroLift is for patients who…

  • Want an alternative to medical therapy.

  • Are concerned about surgery.

  • Want to preserve sexual function.
  • Are concerned about complications.
  • Want a more rapid recovery.
  • Are 50 years of age or older.
  • Have a prostate less than 100 grams in size.

UroLift is a new way of treating BPH and it’s advantages speaks for themselves.

A minimally invasive procedure, that can be performed in local anesthesia.

  • Can be performed in an outpatient setting.
  • Usually no catheter is required post procedure.
  • Minimal down-time post treatment.
  • Patients can typically obtain normal everyday life after 4 weeks.
  • It’s a 5-15 minutes procedure.
  • 0% reports of sexual dysfunction.


Enlarged Prostate

An enlarged prostate can narrow or even block the urethra, causing bothersome urinary symptoms.

Step 1

The UroLift Delivery Device is placed through the obstructed urethra to access the enlarged prostate.

Step 2

Tiny UroLift Implants are permanently placed to lift and hold the enlarged prostate tissue out of the way and increase the opening of the urethra.

Step 3

The UroLift System treatment provides fast and reliable symptom relief by opening the obstructed urethra. 


Sales contact

Service contact